Published • loading... • Updated
Gilead Sciences (NASDAQ:GILD) Price Target Raised to $126.00
Summary by thecerbatgem.com
This story is only covered by news sources that have yet to be evaluated by the independent media monitoring agencies we use to assess the quality and reliability of news outlets on our platform. Learn more here.1 Articles
1 Articles
Gilead Sciences (NASDAQ:GILD) Price Target Raised to $126.00
Gilead Sciences (NASDAQ:GILD – Free Report) had its price objective raised by Royal Bank Of Canada from $123.00 to $126.00 in a research note issued to investors on Thursday morning,Benzinga reports. They currently have a sector perform rating on the biopharmaceutical company’s stock. GILD has been the subject of a number of other reports. Needham […]
Coverage Details
Total News Sources1
Leaning Left0Leaning Right0Center0Last UpdatedBias DistributionNo sources with tracked biases.
Bias Distribution
- There is no tracked Bias information for the sources covering this story.
Factuality
To view factuality data please Upgrade to Premium
